Hot Pursuit     15-Mar-25
Zydus Life’s Gujarat facility clears USFDA inspection with zero observations
Zydus Lifesciences has announced that the US Food and Drug Administration (USFDA) conducted a surveillance inspection at the company’s Active Pharmaceutical Ingredient (API) Unit 1, located in Ankleshwar, Gujarat.

The said inspection was conducted from 10 March to 14 March 2025 and concluded with zero observations from the regulatory body.

The official announcement was made on 14 March 2025.

Zydus Lifesciences is a discovery-driven, global life sciences company that discovers, develops, manufactures, and markets a broad range of healthcare therapies.

The company reported a 29.62% jump in consolidated net profit of Rs 1,023.5 crore in Q3 FY25 compared with Rs 789.6 crore in Q3 FY24. Revenue from operations increased 16.96% YoY to Rs 5,269.1 crore during the quarter.

Shares of Zydus Lifesciences fell 0.73% to end at Rs 882.55 on Thursday, 13 March 2025.

Previous News
  Zydus Lifesciences receives EIR for facility at Jarod, Vadodara
 ( Corporate News - 04-Dec-25   15:48 )
  Zydus Life gets US FDA nod for generic version of antidiabetic combination drug Glyxambi
 ( Hot Pursuit - 28-Nov-25   09:21 )
  Zydus Life rises after inking exclusive licensing deal with RK Pharma for US oncology product
 ( Hot Pursuit - 26-Nov-25   13:30 )
  Zydus enters into licensing and commercialization agreement with RK Pharma Inc.
 ( Corporate News - 26-Nov-25   13:15 )
  Zydus Lifesciences Ltd rises for third consecutive session
 ( Hot Pursuit - 26-Nov-25   13:05 )
  Stock Alert: Zydus Lifescience, United Breweries, Nelco, NCC, Refex Inds
 ( Market Commentary - Stock Alert 26-Nov-25   07:50 )
  Zydus receives USFDA approval for Verapamil Hydrochloride Extended-Release Tablets
 ( Corporate News - 25-Nov-25   19:30 )
  Zydus Lifesciences
 ( Analyst Meet / AGM - Conference Call 18-Nov-25   12:13 )
  Zydus receives USFDA approval for Leuprolide Acetate injection
 ( Corporate News - 14-Nov-25   18:49 )
  Zydus receives China NMPA approval for Venlafaxine ER Capsules
 ( Corporate News - 11-Nov-25   10:09 )
  Zydus Lifesciences gets USFDA tentative Nod for Olaparib Tablets
 ( Hot Pursuit - 10-Nov-25   09:29 )
Other Stories
  Kaynes Tech denies auditor change plans
  09-Dec-25   18:07
  Solarworld Energy gains after inking BESPA to develop BESS in Gujarat
  09-Dec-25   15:30
  Rishabh Instruments rises on securing Rs 10-cr European order
  09-Dec-25   15:07
  Sambhv Steel jumps after board OKs capacity expansion plans
  09-Dec-25   15:01
  eClerx Services Ltd leads losers in 'A' group
  09-Dec-25   15:00
  TV Vision Ltd leads losers in 'B' group
  09-Dec-25   14:45
  Volumes spurt at ERIS Lifesciences Ltd counter
  09-Dec-25   14:30
  Suzlon Energy Ltd up for third straight session
  09-Dec-25   13:05
  Regency Ceramics jumps on securing Rs 7-cr order from GG PROBUILD
  09-Dec-25   13:00
  AB Real Estate arm clocks over Rs 1,800 cr sales in Gurugram project
  09-Dec-25   12:52
Back Top